Skip to main content
Fig. 2 | Cardiovascular Diabetology

Fig. 2

From: FSTL3 partially mediates the association of increased nonalcoholic fatty liver disease fibrosis risk with acute myocardial infarction in patients with type 2 diabetes mellitus

Fig. 2

Hepatic expression of FSTL3 was increased in patients with T2DM and NAFLD with fibrosis. A: GEO database analysis showed FSTL3 expression in the liver of NAFLD fibrosis patients was increased. B–C: H&E staining and immunohistochemical staining of FSTL3 in liver biopsy specimens from 30 NAFLD patients with significant and advanced fibrosis (F2 and F3) and 30 NAFLD patients with fibrosis stage F0 and F1

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840